Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
The DOI matches its Crossref record; 70 of the 72 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Invasive candidiasis (IC) is an important healthcare-related infection, with increasing incidence and a crude mortality exceeding 50%. Numerous treatment options are available yet comparative studies have not identified optimal therapy. METHODS: We conducted an individual patient-level quantitative review of randomized trials for treatment of IC and to assess the impact of host-, organism-, and treatment-related factors on mortality and clinical cure. Studies were identified by searching computerized databases and queries of experts in the field for randomized trials comparing the effect of ≥2 antifungals for treatment of IC. Univariate and multivariable analyses were performed to determine factors associated with patient outcomes. RESULTS: Data from 1915 patients were obtained from 7 trials. Overall mortality among patients in the entire data set was 31.4%, and the rate of treatment success was 67.4%. Logistic regression analysis for the aggregate data set identified increasing age (odds ratio [OR], 1.01; 95% confidence interval [CI], 1.00-1.02; P = .02), the Acute Physiology and Chronic Health Evaluation II score (OR, 1.11; 95% CI, 1.08-1.14; P = .0001), use of immunosuppressive therapy (OR, 1.69; 95% CI, 1.18-2.44; P = .001), and infection with Candida tropicalis (OR, 1.64; 95% CI, 1.11-2.39; P = .01) as predictors of mortality. Conversely, removal of a central venous catheter (CVC) (OR, 0.50; 95% CI, .35-.72; P = .0001) and treatment with an echinocandin antifungal (OR, 0.65; 95% CI, .45-.94; P = .02) were associated with decreased mortality. Similar findings were observed for the clinical success end point. CONCLUSIONS: Two treatment-related factors were associated with improved survival and greater clinical success: use of an echinocandin and removal of the CVC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Observational studies do, however, suggest that mortality may increase after intervals exceeding 3-5 hours from hospital arrival and/or sepsis recognition (98,111,119,120).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [120]
In the citing paper
“Two RCTs have been published (119, 120); one failed to achieve a difference in time-to-antimicrobials between arms (120) and the other found no significant difference in mortality despite a 90-minute difference in median time interval to antimicrobial administration (119).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [120]
In the citing paper
“Source control of infectious foci was associated with improved survival in recent observational and cluster randomized studies (120,263,264).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [120]
In the citing paper
“Treatment with FLC often fails despite isolates being drug susceptible when tested in vitro, and rates of persistent candidemia are often higher in patients treated with FLC rather than with echinocandins 58 .”
From Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia (2018) · cites this paper as [58]
In the citing paper
“The most recent Infectious Disease Society of America (IDSA)125 and European guidelines126,127 recommend echinocandins as first-line initial treatment for most invasive candidiasis in both neutropenic and non-neutropenic patients prior to identification to the species level due to their broad spectrum of activity, favorable side effect profile, mortality benefit, and the increasing incidence of az”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [130]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 3×
“mon cause of nosocomial bloodstream infection [1–4].”
BackgroundMermel, L. A., Allon, M., Bouza, E., Craven, D. E., Flynn, P., O'Grady, N. P., Raad, I. I., Rijnders, B. J. A., Sherertz, R. J., & Warren, D. K. (2009) · Clinical Infectious Diseases · doi:10.1086/599376 · Cited by 3,638
Blacklow, N. R., Gorbach, S. L., & Bartlett, J. G. (1992) · Cited by 2,753
Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578
Biofilms and Device-Associated Infections
Donlan, R. M. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010226 · Cited by 1,504
Critically Ill Patients With 2009 Influenza A(H1N1) Infection in Canada
Kumar, A. (2009) · JAMA · doi:10.1001/jama.2009.1496 · Cited by 1,425
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286
Cited by
Items 501–600 of 804
What’s new in antimicrobial use and resistance in critically ill patients?
Bassetti, M., Nicolau, D. P., & Calandra, T. (2013) · Intensive Care Medicine · doi:10.1007/s00134-013-3190-7 · Cited by 8
Prognostic factors for candidaemia in intensive care unit patients: a retrospective analysis
Kawano, Y., Togawa, A., Nakamura, Y., Mizunuma, M., Yamasaki, R., Hoshino, K., Nishida, T., & Ishikura, H. (2016) · Singapore Medical Journal · doi:10.11622/smedj.2016113 · Cited by 8
Tonini, J., Bailly, S., Gautier‐Veyret, E., Wambergue, C., Pelloux, H., Thiébaut, A., Cornet, M., Stanke‐Labesque, F., & Maubon, D. (2015) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000199 · Cited by 10
Current and emerging pharmacotherapy for the treatment of infections following open-heart surgery
Giacobbe, D. R., Corcione, S., Salsano, A., Puente, F. D., Pinna, S. M., Rosa, F. G. D., Mikulska, M., Santini, F., & Viscoli, C. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1574753 · Cited by 9
Aljeboori, Z., Gorelik, A., Jenkins, E., McFarlane, T., & Darvall, J. N. (2018) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)00971-7 · Cited by 8
Candida guilliermondii-induced chorioretinitis in a patient with eating disorder
Tamura, A., Kawamoto, D., Minami, K., Yasuda, S., Tsujimoto, H., Tsuda, Y., Mizumoto, K., & Suzuki, H. (2020) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2020.11.005 · Cited by 8
Moni, M., Sidharthan, N., Sudhir, S., Prabhu, B., Nampoothiri, V., James, J., Philip, J. M., Thomas, J., Antony, R., Mohamed, Z. U., et al. (2022) · Medicine · doi:10.1097/md.0000000000028906 · Cited by 8
Management of candidemia in patients withClostridium difficileinfection
Falcone, M., Venditti, M., Sanguinetti, M., & Posteraro, B. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2016.1197118 · Cited by 8
Pieralli, F., Dentali, F., Giusti, M., Ciarambino, T., Mazzone, A., Concia, E., Sanguinetti, M., Nallino, M. G., Morana, I., Santini, C., et al. (2020) · Infection · doi:10.1007/s15010-020-01535-z · Cited by 8
Self-citationReboli, A. C. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu160 · Cited by 8
Self-citationKlyasova, G. A., Malchikova, A. O., Tandilova, K. S., Блохина, Е. В., Parovichnikova, E. N., Кравченко, С. К., & Vg, S. (2019) · Terapevticheskii arkhiv · doi:10.26442/00403660.2019.08.000385 · Cited by 8
Lodise, T. P., Garey, K. W., Aram, J. A., Nathanson, B. H., & Redell, M. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf472 · Cited by 8
Clinical predictive models of invasive Candida infection: A systematic literature review
Rauseo, A. M., Aljorayid, A., Olsen, M. A. A., Larson, L., Lipsey, K. L., Powderly, W. G., & Spec, A. (2021) · Medical Mycology · doi:10.1093/mmy/myab043 · Cited by 9
Liu, F., Shao, X., Dong, Z., Tang, K., Zhong, L., Xu, W., Chen, Z., Zheng, C., Zhang, K., Cai, J., et al. (2023) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-023-04672-z · Cited by 7
Controversies in Candida management
Zakhem, A. E., Saad, H. A., Tayyar, R., & Kanj, S. S. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.10.008 · Cited by 9
Purisco, S. U., Martins, M. A., Szeszs, M. W., Silva, D. D. M. C. E., Pukinskas, S. R. B. S., Bonfietti, L. X., Baez, A. A., & Melhem, M. D. S. C. (2012) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2012.00838.x · Cited by 9
Stempel, J. M., Farmakiotis, D., Tarrand, J. J., & Kontoyiannis, D. P. (2016) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.04.001 · Cited by 7
Ryder, J. H., Schooneveld, T. C. V., Lyden, E. R., Ramahi, R. E., & Stohs, E. J. (2022) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2022.209 · Cited by 7
Rezafungin and invasive candida infections: a new game changing antifungal?
Guinea, J. (2022) · The Lancet · doi:10.1016/s0140-6736(22)02371-6 · Cited by 8
Epidemiology of Candidemia in Mashhad, Northeast Iran: A Prospective Multicenter Study (2019–2021)
Dolatabadi, S., Najafzadeh, M. J., Raeisabadi, A., Zarrinfar, H., Jalali, M., Spruijtenburg, B., Meijer, E. F. J., Meis, J. F. G. M., Lass‐Flörl, C., & de Groot, T. (2024) · Journal of Fungi · doi:10.3390/jof10070481 · Cited by 8
Carvalho, L. A. D. C., Remuzgo, C., Perez, K. R., & Machini, M. T. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.09.010 · Cited by 7
Tenorio, T., Grau, S., Luque, S., Fortün, J., Liaño, F., & Roberts, J. A. (2019) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000595 · Cited by 7
Higashi, Y., Niimi, H., Sakamaki, I., Yamamoto, Y., & Kitajima, I. (2020) · Scientific Reports · doi:10.1038/s41598-020-62276-5 · Cited by 7
Zhong, S., Zhu, X., Zhao, L., Song, Y., Yu, J., Zheng, Z., & Zang, B. (2021) · Pharmaceutical Research · doi:10.1007/s11095-020-02980-z · Cited by 7
Infection in the Patient With Cancer
Freifeld, A. G., & Kaul, D. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00034-7 · Cited by 11
Speight, C. C., Williamson, J. E., Ebied, A. M., Medaris, L. A., McCurdy, L., & Hammer, K. L. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad388 · Cited by 7
Effect of ferrocene-substituted porphyrin RL-91 on Candida albicans biofilm formation
Lippert, R., Vojnović, S., Mitrović, A., Jux, N., Ivanović‐Burmazović, I., Vasiljević, B., & Stankovic, N. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.05.061 · Cited by 7
Kawai, A., Yamagishi, Y., & Mikamo, H. (2017) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2016.574 · Cited by 7
Klug entscheiden in der Infektiologie: Choosing wisely
Draenert, R., & Jung, N. (2020) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-020-0342-x · Cited by 7
Cisneros, J. M., Neth, O., & Pachón, J. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis524 · Cited by 7
Logan, C., Allebone-Salt, P. E., Mazzella, A., Hemsley, C. J., Goodman, A. L., Ward, C., Fife, A., Schelenz, S., Abdolrasouli, A., & Bicanic, T. A. (2026) · Journal of Infection · doi:10.1016/j.jinf.2026.106692 · Cited by 7
The Silent Pandemic: Antifungal Resistance and the Future of Invasive Fungal Disease Management
Bagga, R., & Sridhar, K. K. (2026) · Microorganisms · doi:10.3390/microorganisms14030599 · Cited by 6
Kurland, S., Furebring, M., Löwdin, E., Olaison, L., & Sjölin, J. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf312 · Cited by 6
Paulo, E. A., de Souza, C. M., Perini, H. F., Almeida, R. S., Costa, I. C., Pavanelli, W. R., Furlaneto-Maia, L., & Furlaneto, M. C. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106186 · Cited by 6
Maertens, J. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-44080-9_37 · Cited by 8
Park, J. Y., Yang, K. M., Kwak, J. Y., & Jung, Y. T. (2024) · Surgical Infections · doi:10.1089/sur.2023.333 · Cited by 6
Prusty, J. S., Kumar, A., & Kumar, A. (2024) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2024.2418125 · Cited by 8
Puesta al día en la candidiasis invasora en el paciente crítico no neutropénico
Zaragoza, R., Ramírez, P., Borges-Sa, M., & Pemán, J. (2016) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2016.03.001 · Cited by 8
Candidaemia Mortality Has not Changed Over the Last 2 Decades in Brazil
Lana, D. F. D., Falci, D. R., Sanha, V., Filho, S. D. J., Schuch, F. B., & Pasqualotto, A. C. (2020) · Mycopathologia · doi:10.1007/s11046-020-00466-5 · Cited by 6
Candida Infections in Solid Organ Transplantation
Barros, N., & Mansour, M. K. (2021) · Springer eBooks · doi:10.1007/978-3-030-25869-6_43 · Cited by 7
Tsukamoto, H., Higashi, T., Kodawara, T., Watanabe, K., Hida, Y., Iwasaki, H., & Goto, N. (2022) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-022-04499-0 · Cited by 6
Sprute, R., Grothe, J. H., Heringer, S., & Cornely, O. A. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac344 · Cited by 7
Candida glabratafungaemia at an Australian cancer centre: epidemiology, risk factors and therapy
Trubiano, J. A., Leung, V. K. Y., Worth, L. J., Teh, B. W., Thursky, K., & Slavin, M. A. (2015) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2015.1023724 · Cited by 6
Has the Optimal Therapy for Invasive Candidiasis Now Been Defined?
Andes, D. R. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy830 · Cited by 6
Self-citationPhage nanoparticle as a carrier for controlling fungal infection
Xu, S., Zhang, G., Wang, M., Lin, T., Liu, W. Y., & Wang, Y. (2022) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-022-11932-z · Cited by 6
Fungal Biofilms: In Vivo Models for Discovery of Anti-Biofilm Drugs
Nett, J. E., & Andes, D. R. (2015) · ASM Press eBooks · doi:10.1128/9781555817466.ch2 · Cited by 7
Self-citationThe Role of Resistance in Candida Infections: Epidemiology and Treatment
Sobel, J. D., & Akins, R. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-47266-9_18 · Cited by 7
Self-citationGebretekle, G. B., Fentie, A. M., Gebremariam, G. T., Ali, E. E., Erku, D., Alemayehu, T., Abebe, W., & Sander, B. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-08662-3 · Cited by 7
Candidemia in the ICU: Does Initial Antifungal Matter?*
Bennett, J. E., & Powers, J. H. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000002903 · Cited by 6
Brandt, F. P., Sawazaki, J. A., & Cavalcante, R. D. S. (2024) · Medical Mycology · doi:10.1093/mmy/myae069 · Cited by 5
Gieburowski, J. T., Psaltikidis, E. M., de Lima, T. C., Conterno, L. D. O., Trabasso, P., Moretti, M. L., & Resende, M. R. (2024) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.19091 · Cited by 5
Almajid, A., Zeidan, A. A., Alsaihati, F., Alghashmari, K., Almousa, Z., Ashour, T., Almarwani, S., Alqahtani, F., Alqahtani, M., & Aljishi, Y. (2025) · Cureus · doi:10.7759/cureus.89455 · Cited by 6
Management of invasive candidiasis in nonneutropenic ICU patients
Weiss, E., & Timsit, J. (2014) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936114562586 · Cited by 7
Does leukotriene F4 play a major role in the infection mechanism of Candida sp.?
Melo, C. F. O. R., Bachur, L. F., Delafiori, J., Dabaja, M. Z., de Oliveira, D. N., Guerreiro, T. M., Tararam, C. A., Busso-Lopes, A. F., Moretti, M. L., & Catharino, R. R. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104394 · Cited by 5
Theodore, D., Henneman, A. D., Loo, A. S., Shields, R. K., Eschenauer, G. A., Sobieszczyk, M. E., & Kubin, C. J. (2024) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkae175 · Cited by 5
Antimicrobial Tolerance in Cross-Kingdom Dual-Species Biofilms Formed by Fungi and Bacteria
Kurakado, S., Matsumoto, Y., Eshima, S., & Sugita, T. (2024) · Medical Mycology Journal · doi:10.3314/mmj.24.004 · Cited by 5
Droney, M., Reed, E. E., Sarwar, S., Coe, K. E., & Tran, N. N. (2025) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaf026 · Cited by 5
Nagamizu, M., Hotta, Y., Noda, M., Nakamura, D., Hori, M., Otsuka, Y., Takemoto, R., Horita, Y., Wakita, E., Morishita, N., et al. (2025) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2025.102654 · Cited by 5
Fungal Infections in People Who Use Drugs
Gonzales, J. P., & Ostrosky-Zeichner, L. L. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf107 · Cited by 5
Kurland, S., Löwdin, E., Furebring, M., Shams, A., Chryssanthou, E., Lagerbäck, P., Tängdén, T., Breuer, O., & Sjölin, J. (2021) · Mycoses · doi:10.1111/myc.13386 · Cited by 5
Zacharioudakis, I. M., Zervou, F. N., Marsh, K. L., Siegfried, J., Yang, J. Z., Decano, A., Dubrovskaya, Y., Mazo, D., & Aguero‐Rosenfeld, M. E. (2023) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2023.116107 · Cited by 5
An update on pharmacotherapy for fungal infections in allogeneic stem cell transplant recipients
Panagopoulou, P., & Roilides, E. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2387686 · Cited by 6
Kanno, T., Takekawa, D., & Miyakawa, Y. (2015) · Journal of Applied Microbiology · doi:10.1111/jam.12745 · Cited by 6
Does the current treatment of invasive fungal infection need to be reviewed?
Martín‐Peña, A., Aguilar‐Guisado, M., & Cisneros, J. M. (2013) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2013.02.008 · Cited by 7
Micafungin induced apoptosis in Candida parapsilosis independent of its susceptibility to micafungin
Shirazi, F., Lewis, R. E., & Kontoyiannis, D. P. (2015) · Microbial Cell · doi:10.15698/mic2015.11.236 · Cited by 5
Antimicrobial Stewardship Management of Infections: Beyond the Costs of Antimicrobials
Goff, D. A., Bauer, K. A. A., & Mangino, J. E. (2012) · Cited by 6
Multani, A., Rustagi, A., Epstein, D. J., Gómez, C. A., Budvytiene, I., Banaei, N., Brown, J. W., & Liu, A. Y. (2019) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2019.03.011 · Cited by 5
Lee, K.-T., Lee, D., Choi, J., Park, J., Park, K. D., Lee, J.-S., & Bahn, Y. (2022) · The Journal of Microbiology · doi:10.1007/s12275-022-2016-0 · Cited by 6
Candida Biofilms : Development, Architecture, and Resistance
Chandra, J., & Mukherjee, P. K. (2015) · ASM Press eBooks · doi:10.1128/9781555817466.ch6 · Cited by 11
Okinaka, K. (2016) · Medical Mycology Journal · doi:10.3314/mmj.16.003 · Cited by 5
Épidémiologie des candidoses invasives en France
Charles, P., Large, A., Quenot, J., & Dalle, F. (2016) · Réanimation · doi:10.1007/s13546-016-1183-6 · Cited by 5
Vesicle inhibition reduces Candida biofilm resistance
Kim, M.-J., Żarnowski, R., Jones, R., Nett, J. E., & Andes, D. R. (2025) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00045-25 · Cited by 4
Self-citationCandidemia in Left Ventricular Assist Device Recipients: Incidence, Risk Factors, and Outcomes
Anderson, R., Pouch, S. M., Busch, L. M., Hayes, T., Sennhauser, S., Chan, J. L., & Eichenberger, E. M. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf251 · Cited by 4
Clinical Utility of the T2Candida Panel: A Real-World Analysis of More Than 2000 Cases
Lötsch, F., Bouvier-Azula, L., Barousch, W., Camp, I., Starzengrüber, P., Makristathis, A., & Willinger, B. (2025) · Mycopathologia · doi:10.1007/s11046-025-00979-x · Cited by 4
Zaragoza, R., Llinares, P., Maseda, E., Ferrer, R., & Rodríguez, A. H. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.05.005 · Cited by 4
Bond, A., Kopczynska, M., Conley, T. E., Teubner, A., Taylor, M., Abraham, A., Pironi, L., & Lal, S. (2022) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.2451 · Cited by 4
Villanueva-Cotrina, F., Béjar, V., Guevara, J., Cajamarca, I., Medina, C., Mujica, L., & Lescano, A. G. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-10044-5 · Cited by 4
Cornely, O. A., Bassetti, M., García‐Vidal, C., Hoenigl, M., Maertens, J. A., Martín‐Loeches, I., Mira, J. P., & White, P. L. (2025) · Mycoses · doi:10.1111/myc.70135 · Cited by 4
Automated, electronic monitoring for early detection of sepsis
Rauch, S., Fischer, M. J., Martin, C., & Sablotzki, A. (2013) · Critical Care · doi:10.1186/cc12457 · Cited by 4
In Vivo Candida Device Biofilm Models
Andes, D. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_7 · Cited by 5
Self-citationHasan, M. J., Neelotpol, S., & Rabbani, R. (2022) · The Journal of Critical Care Medicine · doi:10.2478/jccm-2022-0006 · Cited by 4
Zhang, M., Li, R., Zhou, Y., Xie, R., Ma, J., Liu, H., Qin, Y., Zhao, M., Duan, N., Ye, P., et al. (2022) · Pathogens · doi:10.3390/pathogens11121522 · Cited by 4
Kim, J. H., Suh, J. W., & Kim, M. J. (2023) · Journal of Fungi · doi:10.3390/jof9050539 · Cited by 4
Are Echinocandins Better Than Azoles for Invasive Candidiasis?
Revankar, S. G., & Sobel, J. D. (2012) · Current Fungal Infection Reports · doi:10.1007/s12281-012-0124-8 · Cited by 4
Self-citationEnfermedades invasivas por hongos levaduriformes en pacientes quemados graves
Escrig, A. I. R., García‐Vidal, C., & Salavert, M. (2016) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2016.02.002 · Cited by 4
Infection in the Patient with Cancer
Freifeld, A. G., & Kaul, D. R. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00036-9 · Cited by 4
El-Housseiny, G. S., Shams, G., Ghobashi, Z., Mamdouh, R., Almaqsod, I., & Saleh, S. E. (2021) · Archives of Pharmaceutical Sciences Ain Shams University · doi:10.21608/aps.2021.80383.1063 · Cited by 5
Sobel, J. D. (2015) · Springer eBooks · doi:10.1007/978-3-319-13090-3_8 · Cited by 4
Self-citationAVALIAÇÃO DA ATIVIDADE ANTIFÚNGICA DE Curcuma longa SOBRE Candida parapsilosis
Pacheco, D. D. R., Soares, D. E. D., Silva‐Neto, C. D. M. E., da Silva, G. A., & do Prado, R. S. (2015) · Revista de Patologia Tropical / Journal of Tropical Pathology · doi:10.5216/rpt.v44i3.38022 · Cited by 4
Rizwan, R., Memon, Z., Shaheen, S., Afridi, F. I., & Zaib, M. (2018) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2018.99054 · Cited by 4
Adolescent eating disorder with catheter‐related bloodstream infection
Tamura, A., Minami, K., Tsuda, Y., Mizumoto, K., & Suzuki, H. (2020) · Pediatrics International · doi:10.1111/ped.14511 · Cited by 4
Colombo, A. L., Guimarães, T., Camargo, L. F. A., Richtmann, R., Queiroz‐Telles, F., Salles, M. J. C., da Cunha, C. A., Shikanai‐Yasuda, M. A., Moretti, M. L., & Nucci, M. (2012) · The Brazilian Journal of Infectious Diseases · doi:10.1016/s1413-8670(12)70336-7 · Cited by 6
Diagnosis and Management of Invasive Candida Infections in Critically Ill Patients
Zakhem, A. E., Istambouli, R., Jabbour, J.-F., Hindy, J.-R., Gharamti, A. A., & Kanj, S. S. (2022) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1741009 · Cited by 4
Hayashi, K., Hashimoto, C., Ueda, K., Nakaya, Y., Suzuki, A., Hayashi, M., Sato, M., & Kobayashi, Y. (2025) · Infectious Disease Reports · doi:10.3390/idr17020036 · Cited by 3
Tang, J., Cai, L., He, H., Li, X., Liang, S., Zhang, L., Xue, X., Xu, B., & Pan, W. (2025) · Medical Mycology · doi:10.1093/mmy/myaf087 · Cited by 3
Time to positivity as a diagnostic tool for catheter-related candidemia: A species-specific analysis
Albanell‐Fernández, M., Vergara, A., Cardozo, C., Herrera, S., Verdejo, M. Á., Malano-Barletta, D., Pitart, C., Meneses, M. H., Cuervo, G., García‐Vidal, C., et al. (2026) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2026.108847 · Cited by 3
Detection and Control of Candida auris in Healthcare Settings
Kwon, Y. J., & Shin, J. H. (2022) · Korean Journal of Healthcare-Associated Infection Control and Prevention · doi:10.14192/kjicp.2022.27.1.4 · Cited by 3
A Dedicated Mycosis Flask Increases the Likelihood of Identifying Candidemia Sepsis
Ahlström, M. G., Antsupova, V. S., Pedersen, M., Johansen, H. K., Hansen, D. S., & Knudsen, J. D. (2023) · Journal of Fungi · doi:10.3390/jof9040441 · Cited by 3
Antifungal Dosing Strategies for Critically Ill Patients
Dietrich, T., Pfeifer, C. J., Aker, K. E., & Bergman, S. (2017) · Current Fungal Infection Reports · doi:10.1007/s12281-017-0270-0 · Cited by 3
Sanna, M., Caocci, G., & Nasa, G. L. (2017) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2017.047 · Cited by 3
Metadata
- Authors
- Andes, D. R., Safdar, N., Baddley, J. W., Playford, G., Reboli, A. C., Rex, J. H., Sobel, J. D., Pappas, P. G., Kullberg, B. J., & for the Mycoses Study Group
- Affiliations
- University of Wisconsin–Madison (US)
- University of Alabama at Birmingham (US)
- The University of Queensland (AU)
- Rutgers, The State University of New Jersey (US)
- AstraZeneca (United States) (US)
- Wayne State University (US)
- Radboud University Nijmegen (NL)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-03-12
- Volume
- 54
- Issue
- 8
- Pages
- 1110-1122
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2134827411
- Cited by
- 793
- References
- 72
- Citations by year
- 2026: 20 · 2025: 46 · 2024: 46 · 2023: 45 · 2022: 42 · 2021: 64 · 2020: 81 · 2019: 46 · 2018: 71 · 2017: 69 · 2016: 58 · 2015: 62 · 2014: 60 · 2013: 54 · 2012: 28
- FWCI
- 45.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- invasive candidiasis, candidemia, antifungal therapy, echinocandins, central venous catheter removal, mortality, clinical cure, risk factors, immunosuppression, Candida tropicalis, APACHE II score
- MeSH terms
- Adult, Aged, Antifungal Agents, Catheterization, Central Venous, Female, Humans, Male, Middle Aged, Randomized Controlled Trials as Topic, Treatment Outcome, Withholding Treatment, Echinocandins, Candidiasis, Invasive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.